Table 1. Reported diseases associated with anti–TNF-α therapy and therapy implicated for 105 cases of NTM disease, US Food and Drug Administration MedWatch database, 1999–2006*.

Disease	Infliximab	Etanercept	Adalimumab
Rheumatoid arthritis (n = 73)	51	17	5
Ankylosing spondylitis (n = 5)	1	3	1
Psoriasis (n = 4)	2	2	0
Crohn disease (n = 8)	8	0	0
Other (n = 15)†	11	3	1

*TNF-α, tumor necrosis factor-α; NTM, nontuberculous mycobacteria.
†Includes Wegener granulomatosis (n = 2), dermatomyositis (n = 1), uveitis (n = 1), juvenile rheumatoid arthritis (n = 1), and not reported (n = 10).